Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Supply of Commercial-Grade DNA Extraction Kits

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Energy → Argonne National Labor - DOE ContractorView Agency

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Lemont, IL, 60439, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Energy → Argonne National Labor - DOE Contractor
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Energy → Argonne National Labor - DOE Contractor
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Procurement and delivery of off-the-shelf DNA extraction kits meeting research-grade purity, yield, and reproducibility standards, free from contaminants and suitable for PCR and sequencing.

Similar Contracts

NAICS: 325412
New
Federal
ModafinilThe Defense Logistics Agency is preparing to issue a national requirements contract for Modafinil Tablets under solicitation number SPE2D2-26-R-0014, with a projected release date in September 2026. The contract will be unrestricted and fully competitive, solicited under FAR Part 12 as a commercial item, and structured as a firm-fixed price, requirements-type agreement with a one-year base period and four optional one-year extensions. The products required include 100 MG tablets in 30 and 90 count bottles and 200 MG tablets in 30, 90, and 100 count bottles. This contract will serve as the national supply source for authorized federal customers including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons, all procuring through the DLA and VA prime vendor programs. Annual usage quantities will be detailed in the solicitation’s schedule, and all eligible sources may submit proposals for consideration. The solicitation will be posted on the DLA Bid Board System and SAM.gov, with automated notifications recommended for tracking updates. The North American Industry Classification System code is 325412, and the responsible office is located in Philadelphia, Pennsylvania under DLA Troop Support, a Department of Defense organization. Primary point of contact is Charlene Fernandez, reachable by phone or email, with Jason Wray listed as secondary contact. The agency retains the right to adjust the solicitation timeline, and interested parties are advised to monitor the official portals closely for any changes prior to and following the release.
DLA Troop Support

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 325412
New
Federal
Methylphenidate ERThe Defense Logistics Agency is preparing to issue a national requirements contract for Methylphenidate ER Tablets in 18MG, 27MG, 36MG, and 54MG strengths, packaged in 100-count bottles. This procurement will be conducted as an unrestricted, fully competitive acquisition under FAR Part 12 as a commercial item, using a firm-fixed-price, requirements-type contract structure with a one-year base period and four one-year option periods. The resulting contract will serve as the national supply source for Methylphenidate ER Tablets, supplying the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Annual usage estimates will be specified in the solicitation’s schedule, and all eligible sources may submit proposals. The contract is designed to ensure consistent, nationwide availability of this critical medication. The solicitation, numbered SPE2D226R0013, is currently in the pre-solicitation phase with a projected release date in September 2026, though the agency retains the right to issue it earlier or later. The contract will be posted on both the DLA Bid Board System and SAM.gov, and interested parties are encouraged to monitor these sites and set up automated notifications for updates. All correspondence should be directed to Jeremy Brown at jeremy.brown@dla.mil or (445) 737-5419, with Jason Wray available as a secondary point of contact. The acquisition is managed by DLA Troop Support, headquartered in Philadelphia, Pennsylvania, and is classified under NAICS code 325412 for pharmaceutical preparation manufacturing.
DLA Troop Support

POSTED

1 day ago

DEADLINE

N/A
View Details